Last but certainly not least, we are happy to introduce Dr. Reshma N. Singh as one of our panelists. The panel discussion will be taking place on Sunday May 26th in the Shaw Conference Centre Saloon 2.

After graduating with a Bachelor of Science degree in Chemistry from the University of Guyana in 2006, Reshma Singh spend three and half years working in the food industry as a Quality Control and Assurance Chemist. In 2009, she became a graduate student in Dr. Jed Harrison’s research group at the University of Alberta. Her Ph.D. research focused on the detection of small molecules using silicon and cobalt nano columned-thin films and LASER desorption/ionization.

In 2015, she joined Agriculture and Agri-Food Canada (AAFC) as a Research Participant working on an Alberta Innovates grant entitled “Addressing food quality challenges in Alberta’s aquaculture industry”. Her focus was the detection and quantification of off-flavour compounds using Gas Chromatography-Mass Spectrometry. In 2016, Reshma became a Federal Postdoctoral fellow at AAFC’s Lacombe Research Centre, with her work switching to the detection and identification of flavour compounds in meat.

Interested in learning more about Dr. Singh? There are still tickets available for the Sunday of the LOGIC 2018 meeting – sign up here before they run out!

We are excited to continue introducing our invited speakers for LOGIC 2018! Dr. Lisa A. Shipley will be joining our Sunday morning panel taking place at the Shaw Conference Centre. Don’t miss your chance to hear about her fascinating career path – register via the CSC website before April 24th!

Dr. Shipley is Vice President of Pharmacokinetics, Pharmacodynamics and Drug Metabolism in Merck Research Laboratories. She is responsible for the all Preclinical ADME, Bioanalytics and Quantitative Pharmacology and Pharmacometrics activities at Merck research sites and support of all programs from discovery through post product launch.  Prior to joining Merck in 2008, Dr. Shipley spent the over 20 years at Eli Lilly and Company in roles of increasing responsibility including the positions of executive director, Lean Six Sigma and vice president Drug Disposition, PK/PD and Trial Simulations. Dr. Shipley obtained her undergraduate degree from McDaniel College and her doctoral degree in Pharmacology and Toxicology from the University of Maryland at Baltimore. Her postdoctoral training was conducted at the Walter Reed Army Institute of Research as a National Research Council Fellow elucidating the metabolism and pharmacokinetics of antileishmanial and antimalarial drugs under development by the U.S. Army.

Dr. Shipley has authored or co-authored three book chapters, over 25 journal articles, 40 abstracts on drug metabolism, pharmacokinetics, analytical assay development, and drug disposition and has been granted five patents. She has chaired sessions at the Gordon Research Conference in Drug Metabolism, the Society of Toxicology, the American Association of Pharmaceutical Sciences, International Conference on Drug Development, PhRMA workshops and the Drug Information Association. She has served as the chair of the Drug Metabolism Technical Group within the Pharmaceutical Research and Manufacturing Association (2007-09), a member of the IQ Consortium and as a member of the International Society of  the Study of Xenobiotics Council (2010-12). She has also served as a reviewer for Drug Metabolism and Disposition, Journal of Clinical Pharmacology, the Journal of Chromatography and Toxicology and Applied Pharmacology, and a lecturer for the University of Indiana School of Medicine and Purdue University. She was awarded the 2000-2001 Chairman’s Ovation Award for leadership in motivating and developing people, the LRL President’s Award for Diversity in 2007, the Chairman’s Award in Environmental Health and Safety in 2013 and was awarded the NAFE Women of Excellence Healthcare Champion in 2017.